Publications

Journal of immunotherapy (Hagerstown, Md. : 1997)

Real-world Outcomes of First-line Anti-PD-1 Therapy for Advanced Melanoma: A Nationwide Population-based Study.

01-10-2020

Journal for immunotherapy of cancer

Reconsidering the management of patients with cancer with viral hepatitis in the era of immunotherapy.

01-10-2020

Annals of oncology : official journal of the European Society for Medical Oncology

Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus.

01-10-2020

European journal of cancer (Oxford, England : 1990)

Survival outcomes of patients with advanced mucosal melanoma diagnosed from 2013 to 2017 in the Netherlands - A nationwide population-based study.

01-09-2020

International journal of cancer

A prospective observational registry evaluating clinical outcomes of Radium-223 treatment in a nonstudy population.

15-08-2020

Clinical cancer research : an official journal of the American Association for Cancer Research

The Outcome of Ex Vivo TIL Expansion Is Highly Influenced by Spatial Heterogeneity of the Tumor T-Cell Repertoire and Differences in Intrinsic In Vitro Growth Capacity between T-Cell Clones.

15-08-2020

Annals of oncology : official journal of the European Society for Medical Oncology

Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma.

01-08-2020

Journal for immunotherapy of cancer

Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up.

01-08-2020

BMC cancer

Evaluating different adoption scenarios for TIL-therapy and the influence on its (early) cost-effectiveness.

31-07-2020

Cancers

Age Does Matter in Adolescents and Young Adults versus Older Adults with Advanced Melanoma; A National Cohort Study Comparing Tumor Characteristics, Treatment Pattern, Toxicity and Response.

27-07-2020

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic.

01-07-2020

Melanoma research

Phase Ib/II trial testing combined radiofrequency ablation and ipilimumab in uveal melanoma (SECIRA-UM).

01-06-2020

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...

Prognostic and predictive role of the tumor immune landscape.

01-06-2020

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...

Cancer management in the era of immunotherapy: much more than meets the eye.

01-06-2020

Annals of oncology : official journal of the European Society for Medical Oncology

Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: review of the literature and personalized risk-based prevention strategy.

01-06-2020

Journal for immunotherapy of cancer

Rechallenge patients with immune checkpoint inhibitors following severe immune-related adverse events: review of the literature and suggested prophylactic strategy.

01-06-2020

Immuno-oncology technology

IOTECH in times of COVID-19.

01-06-2020

Cancers

Surgery for Unresectable Stage IIIC and IV Melanoma in the Era of New Systemic Therapy.

07-05-2020

Clinical cancer research : an official journal of the American Association for Cancer Research

Association of Anti-TNF with Decreased Survival in Steroid Refractory Ipilimumab and Anti-PD1-Treated Patients in the Dutch Melanoma Treatment Registry.

01-05-2020

Pigment cell & melanoma research

Switch to checkpoint inhibition after targeted therapy at time of progression or during ongoing response: A retrospective single-centre experience in patients with BRAF-mutated melanoma.

01-05-2020

Cancers

Healthcare Costs of Metastatic Cutaneous Melanoma in the Era of Immunotherapeutic and Targeted Drugs.

18-04-2020

Nature medicine

Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers.

01-04-2020

European urology oncology

Deferred Cytoreductive Nephrectomy Following Presurgical Vascular Endothelial Growth Factor Receptor-targeted Therapy in Patients with Primary Metastatic Clear Cell Renal Cell Carcinoma: A Pooled Analysis of Prospective Trial Data.

01-04-2020

Journal of geriatric oncology

Treatment of older patients with immune checkpoint inhibitors in routine clinical care as compared to inclusion in pivotal registration trials.

01-04-2020

Oncoimmunology

Response and survival of metastatic melanoma patients treated with immune checkpoint inhibition for recurrent disease on adjuvant dendritic cell vaccination.

22-03-2020

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Cytomegalovirus in Steroid-Refractory Immune Checkpoint Inhibition-Related Colitis.

01-01-2020

Cancers

Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy; The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH?

04-12-2019

Annals of oncology : official journal of the European Society for Medical Oncology

Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis.

01-12-2019

European journal of cancer (Oxford, England : 1990)

A systematic literature review and network meta-analysis of effectiveness and safety outcomes in advanced melanoma.

01-12-2019

Annals of oncology : official journal of the European Society for Medical Oncology

Gender medicine and oncology: report and consensus of an ESMO workshop.

01-12-2019

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Metabolic Biomarker-Based BRAFV600 Mutation Association and Prediction in Melanoma.

01-11-2019

European journal of cancer (Oxford, England : 1990)

Safety and efficacy of nivolumab in challenging subgroups with advanced melanoma who progressed on or after ipilimumab treatment: A single-arm, open-label, phase II study (CheckMate 172).

01-11-2019

Oncoimmunology

Polyfunctional tumor-reactive T cells are effectively expanded from non-small cell lung cancers, and correlate with an immune-engaged T cell profile.

28-10-2019

The New England journal of medicine

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.

17-10-2019

Immuno-oncology technology

The promise of IO and IOTECH.

01-10-2019

European urology

Surgical Safety of Cytoreductive Nephrectomy Following Sunitinib: Results from the Multicentre, Randomised Controlled Trial of Immediate Versus Deferred Nephrectomy (SURTIME).

01-10-2019

Immuno-oncology technology

Getting visible with exciting IO tech!

01-09-2019

European journal of cancer (Oxford, England : 1990)

Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study (CheckMate 172).

01-09-2019

ESMO open

Susceptible loci associated with autoimmune disease as potential biomarkers for checkpoint inhibitor-induced immune-related adverse events.

20-08-2019

ESMO open

Targeting prognostic proinflammatory biomarkers to improve outcome on IO drugs.

20-08-2019

The New England journal of medicine

Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma.

15-08-2019

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology

Sensorineural Hearing Loss After Adoptive Cell Immunotherapy for Melanoma Using MART-1 Specific T Cells: A Case Report and Its Pathophysiology.

01-08-2019

Cancers

Metastatic Uveal Melanoma: Treatment Strategies and Survival-Results from the Dutch Melanoma Treatment Registry.

18-07-2019

Journal for immunotherapy of cancer

Transgenerational transfer of gene-modified T cells.

15-07-2019

The Lancet. Oncology

Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial.

01-07-2019

Future oncology (London, England)

A Phase II, single-arm trial of neoadjuvant axitinib plus avelumab in patients with localized renal cell carcinoma who are at high risk of relapse after nephrectomy (NEOAVAX).

01-07-2019

Nature medicine

Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial.

01-07-2019

Annals of oncology : official journal of the European Society for Medical Oncology

Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma.

01-07-2019

ESMO open

How I treat MSI cancers with advanced disease.

25-06-2019

Annals of oncology : official journal of the European Society for Medical Oncology

Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers.

01-06-2019